Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Warren

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Nature|September 1, 2016
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
The EMBO Journal|May 24, 2011
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesisCharles E Massie, Andy Lynch, Antonio Ramos-Montoya, et al.
Nature|November 4, 2016
Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
A Genetic Polymorphism in <i>CTLA-4</i> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell CarcinomaXiaoyan Liu, Jesse J Swen, Meta H M Diekstra, et al.
European Urology|December 3, 2013
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patientsPrasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F Shariat, et al.
Urologic Oncology|April 8, 2017
Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicityLoes F M van der Zanden, Sita H Vermeulen, Arna Oskarsdottir, et al.
The Journal of Clinical Investigation|November 19, 2010
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humansErik Schoenmakers, Maura Agostini, Catherine Mitchell, et al.
Nature Communications|June 24, 2021
Single cell derived mRNA signals across human kidney tumorsMatthew D Young, Thomas J Mitchell, Lars Custers, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Nature|September 1, 2016
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
The EMBO Journal|May 24, 2011
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesisCharles E Massie, Andy Lynch, Antonio Ramos-Montoya, et al.
Nature|November 4, 2016
Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
A Genetic Polymorphism in <i>CTLA-4</i> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell CarcinomaXiaoyan Liu, Jesse J Swen, Meta H M Diekstra, et al.
European Urology|December 3, 2013
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patientsPrasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F Shariat, et al.
Urologic Oncology|April 8, 2017
Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicityLoes F M van der Zanden, Sita H Vermeulen, Arna Oskarsdottir, et al.
The Journal of Clinical Investigation|November 19, 2010
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humansErik Schoenmakers, Maura Agostini, Catherine Mitchell, et al.
Nature Communications|June 24, 2021
Single cell derived mRNA signals across human kidney tumorsMatthew D Young, Thomas J Mitchell, Lars Custers, et al.
Pageof 9